Jeong Woo Bae

Title: Innovations by Jeong Woo Bae in Pharmaceutical Composition

Introduction

Jeong Woo Bae is an accomplished inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release formulations. His innovative work aims to enhance patient treatment efficiency while minimizing side effects.

Latest Patents

One of Jeong Woo Bae's notable patents is a rivastigmine-containing sustained-release pharmaceutical composition. This invention focuses on a sustained-release preparation that includes a pH-dependent delayed release phase. By controlling the release of the pharmaceutical composition to be minimized in the stomach during the initial stage of administration, it effectively lowers the maximum blood concentration (Cmax) compared to existing products. This innovative approach allows for the maintenance of an effective blood concentration through sustained release, thereby reducing side effects. As a result, the pharmaceutical composition can achieve the same therapeutic effect as existing twice-a-day dosing with only once-a-day administration.

Career Highlights

Jeong Woo Bae is associated with Navipharm Co., Ltd., where he continues to work on advancing pharmaceutical technologies. His dedication to research and development has positioned him as a key figure in the industry.

Collaborations

Jeong Woo Bae collaborates with talented individuals such as Sang Geun Park and Hye Gyeong Shin. Their combined expertise contributes to the innovative projects at Navipharm Co., Ltd.

Conclusion

Jeong Woo Bae's contributions to pharmaceutical innovations, particularly in sustained-release formulations, demonstrate his commitment to improving patient care. His work not only enhances treatment efficiency but also addresses the challenges associated with medication administration.